Futura Medical (FUM LN) All set for MED2002 Phase III trial start in H1 2018 | Horizon Discovery Group (HZD LN) Forecast update post Dharmacon acquisition | IndigoVision Group (IND LN) Strategic objectives progressing; strong H2 expected | Realm Therapeutics (RLM LN) H1 results and proposed £19m equity fundraise | St Ives (SIV LN) Trading update
22 Sep 2017
N+1 Singer - Morning Song 22-09-2017
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Morning Song 22-09-2017
Kin and Carta Plc (KCT:LON), 0 | Indigovision Group (IND:LON), 0 | Futura Medical plc (FUM:LON), 39.4 | Realm Therapeutics (RLM:LON), 0
- Published:
22 Sep 2017 -
Author:
N+1 Singer Team -
Pages:
13
Futura Medical (FUM LN) All set for MED2002 Phase III trial start in H1 2018 | Horizon Discovery Group (HZD LN) Forecast update post Dharmacon acquisition | IndigoVision Group (IND LN) Strategic objectives progressing; strong H2 expected | Realm Therapeutics (RLM LN) H1 results and proposed £19m equity fundraise | St Ives (SIV LN) Trading update